Amgen Inc. buy Royal Bank of Canada
Start price
07.02.24
/
50%
€281.00
Target price
07.02.25
€305.58
Performance (%)
5.84%
Price
04.10.24
€291.20
Summary
This prediction is currently active. The BUY prediction by Royal_Bank_of_Canada shows slight gains of 5.84%. Dividends of €6.20 are taken into consideration when calculating the performance. This prediction currently runs until 07.02.25. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Amgen Inc. | 0.761% | 0.761% |
iShares Core DAX® | -1.114% | 3.430% |
iShares Nasdaq 100 | 1.816% | 6.911% |
iShares Nikkei 225® | 2.113% | 5.501% |
iShares S&P 500 | 2.038% | 5.327% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Amgen Inc. diskutieren
Amgen Inc. (NASDAQ: AMGN) had its price target raised by analysts at Royal Bank of Canada from $303.00 to $329.00. They now have an "outperform" rating on the stock.
Ratings data for AMGN provided by MarketBeat